[Lipiodol transcatheter arterial chemoembolization for non-resectable hepatocellular carcinoma--multicenter cooperative study].

Kawai, S; Tani, M; Mikuriya, S; Inoue, J; Shimamura, Y; Takahashi, A; Masuzawa, M; Jinno, K; Makino, M; Oda, T

Kawai, S; Tani, M; Mikuriya, S; Inoue, J; Shimamura, Y; Takahashi, A; Masuzawa, M; Jinno, K; Makino, M; Oda, T.

Affiliation

Kawai S; Dept. of Surgery, National Medical Center Hospital.

Gan To Kagaku Ryoho ; 17(2): 227-32, 1990 Feb.

Article in Ja | MEDLINE | ID: mdl-2154160

Subject(s)

Carcinoma, Hepatocellular/therapy; Doxorubicin/administration & dosage; Embolization, Therapeutic; Iodized Oil/administration & dosage; Liver Neoplasms/therapy; Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular/mortality; Female; Hepatic Artery; Humans; Liver Neoplasms/mortality; Male; Middle Aged; Multicenter Studies as Topic; Survival Rate

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Doxorubicin / Iodized Oil / Carcinoma, Hepatocellular / Embolization, Therapeutic / Liver Neoplasms Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: Ja Journal: Gan To Kagaku Ryoho Year: 1990 Document type: Article

Search on Google

Add to My VHL

XML

PubMed Links